Abstract | OBJECTIVE: PATIENTS AND METHODS: A prospective, randomized, placebo-controlled, and double-blind study was conducted between May 1, 2016, through March 30, 2017. A total of 49 participants diagnosed with mild-to-moderate CTS were randomized into D5W and control groups. Participants in the D5W group received 1 session of ultrasound-guided PIT with 5 cc of D5W, and the control group received PIT with normal saline. The visual analog scale measured pain as a primary outcome. Secondary outcomes were Boston Carpal Tunnel Syndrome Questionnaire scores, the cross-sectional area of the median nerve, and electrophysiological measurement results. Assessment was performed before injection and at 1, 3, and 6 months post-injection. RESULTS: All patients (data from 30 wrists in each group) completed the study. Compared with the control group, at all post-injection time points, the D5W group had a significant reduction in pain and disability, improvement on electrophysiological response measures, and decreased cross-sectional area of the median nerve. CONCLUSION: Our study reveals that ultrasound-guided PIT with D5W is an effective treatment for patients with mild-to-moderate CTS. TRIAL REGISTRATION: www.ClinicalTrials.gov: NCT02809261.
|
Authors | Yung-Tsan Wu, Tsung-Yen Ho, Yu-Ching Chou, Ming-Jen Ke, Tsung-Ying Li, Chia-Kuang Tsai, Liang-Cheng Chen |
Journal | Mayo Clinic proceedings
(Mayo Clin Proc)
Vol. 92
Issue 8
Pg. 1179-1189
(08 2017)
ISSN: 1942-5546 [Electronic] England |
PMID | 28778254
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Copyright | Copyright © 2017 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved. |
Chemical References |
|
Topics |
- Carpal Tunnel Syndrome
(drug therapy)
- Double-Blind Method
- Glucose
(administration & dosage)
- Humans
- Median Nerve
(diagnostic imaging)
- Pain Measurement
(statistics & numerical data)
- Ultrasonography, Interventional
(methods)
|